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Conclusion: This study demonstrated that silent AF detected by CEM is
common and associated with older age. Further studies are needed to investi-
gate the interest of systematical screening for silent AF for secondary preven-
tion after ischemic stroke.
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Introduction: If the management of atrial fibrillation in its thromboembolic
component knows more adherences to recommendations, it should be noted
that the rhythmic component is experiencing a trend towards acceptance of the
AF at the expense of a restoration strategy sinus rhythm.
Purpose: To evaluate the effectiveness of the drug cardioversion or elec-
trical cardioversion in patients hospitalized in the cardiology department of
HMIMV Rabat.
Materials and Methods: This is a prospective study conducted over a
period of one year, including 45 patients with non-valvular AF, candidates for
chemical or electrical cardioversion. All our patients have undergone transtho-
racic echocardiography, sometimes supplemented with a transesophageal
echocardiography and an assessment of thyroid
Results: The average age of our patients was 52.7 years with a sex ratio
2/1. 25% of our patients had hypertensive heart disease, 8% ischemic heart
disease, 4% dilated cardiomyopathy and the rest had a healthy heart. The
average diameter of the left atrium was 41 cm with an average surface to
19 cm². 60% of our patients have undergone cardioversion by external shock,
and 40% of theme by injection of amiodarone or flecainide. The rate of res-
toration of sinus rhythm was 78%, with a recurrence rate at one month 19%.
The predictive factors of recurrence were an ancient atrial fibrillation, a large
left atrium and a score CHA2DS2-VASC ≥ 1.
Conclusion: This study, showing an acceptable level of restoration and
maintenance of sinus rhythm, confirms the interest of promoting a strategy of
rhythm control, subject to patient selection on predictors of success.
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Transmural APD heterogeneity is thought to play an important role in
homogeneous repolarization of the ventricles. Abnormal heterogeneity of
action potential duration (APD) in ventricles is known to contribute to
arrhythmogenesis. It has been shown to be modulated by electrotonic influ-
ences in small species, yet this finding remains to be confirmed in large mam-
malians.
The goal of the present study was to investigate APD differences between
epi- and endocardium depending on the pacing location and after a reduction
in intercellular coupling in sheep ventricles.
Optical mapping experiments were performed in coronary-perfused wedge
preparations from sheep left (LV; N=8) or right ventricles (RV; N=3). The
wedges were paced at 2Hz on either the endo- or epicardial surface. We also
investigated the effect of carbenoxolone (50 μM) in the RV experiments.
In the LV experiments, we observed a significant APD difference between
endo- (306.45±18.29ms) and epicardium (276.05±9.87ms) when pacing the
endocardium (P<0.01). However, this transmural heterogeneity was lost when
pacing the epicardium, with endocardial APDs of 284.10±25.67 ms vs
289.8±36.24 ms at the epicardium. A similar observation was made in the RV
with a significant increase in epicardial APD when pacing the epicardium
(230.17±11.32 ms) vs the endocardium (217.73±19.50 ms) (P<0.01). Upon
perfusion with carbenoxolone epicardial APDs significantly increased by 10%
(P<0.01) and the difference in epicardial APD between epicardial and endo-
cardial pacing was no longer significant.
In conclusion, we find that the epi- and endocardial APDs are modulated
by the activation sequence. Specifically, we observe a significant increase in
epicardial vs endocardial APD when pacing the epicardium in both the RV
and LV and an associated decrease in transmural APD heterogeneity. This
effect was abolished upon perfusion with carbenoxolone indicating a role for
electronic currents in modulating transmural APD heterogeneity.
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The CHA2DS2-VASc score estimates the risk of stroke in non-valvular
atrial fibrillation (AF). Nonetheless, there are limited data on the risk of
stroke/thromboembolic (TE) complications in AF patients with valvular heart
disease, other than those with valvular prosthesis or rheumatic mitral valve
disease.
Methods: Among 8962 patients with AF seen between 2000 and 2010,
patients were categorised into Group 1 “non valvular AF” (n=6851; 78%),
Group 2 “quasi valvular AF” ie. valve disease with neither rheumatic mitral
stenosis nor valve prothesis (n=1202; 13%) and Group 3 “valvular AF”
(n=909; 9%) using ESC AF guidelines definition.
Results: In group 2, 61% of the patients had mitral regurgitation (n=917,
non severe in 52%, severe in 9%), 24% had aortic regurgitation (n=414, non
severe in 22%, severe in 2%) and 32% had aortic stenosis (n=555, non
severe in 18%, severe in 14%). In group 3, 88% of the patients with valvular
AF had valve prostheses (n=797) and 14% had mitral stenosis (n=124).
After follow up of 884±1084 days, 715 stroke/TE events were recorded.
Group 2 was significantly older, had a higher CHA2DS2-VASc score and
had a higher risk of TE events (relative risk 1.39; 95%CI 1.14-1.69) com-
pared with Group 1. Severe valve disease was not associated with worse
prognosis for stroke/TE events (relative risk 1.12, 95%CI 0.78-1.61). In the
3 groups, stroke/TE risk increased with a higher CHA2DS2-VASc score.
Factors independently associated with increased risk of stroke/TE events
were older age (RR 1.02, 95%CI 1.01-1.03) and higher CHA2DS2-VASc
score (RR 1.33, 95%CI 1.23-1.45). The increased risk of stroke/TE events
in patients from Group 2 (compared to those from Group 1) did not reach
statistical significance in multivariate analysis.
Conclusions: In patients with AF, left-sided valvular heart disease
(excluding mitral stenosis and protheses) was associated with an increased risk
of stroke/TE events. A higher CHA2DS2-VASc score was the main driver of
these events.
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